DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
-6.19%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$106M
AUM Growth
+$106M
(-9.3%)
Cap. Flow
+$581K
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
66.88%
Holding
55
New
8
Increased
10
Reduced
3
Closed
5
Top Buys
| 1 |
Arcturus Therapeutics
ARCT
|
$1.3M |
| 2 |
Riot Platforms
RIOT
|
$1.3M |
| 3 |
ECI
ENCISION INC
ECI
|
$1.13M |
| 4 |
OCRX
Ocera Therapeutics, Inc.
OCRX
|
$744K |
| 5 |
CRDC
CARDICA INC COM NEW (DE)
CRDC
|
$493K |
Top Sells
| 1 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
$2.6M |
| 2 |
AMPE
Ampio Pharmaceuticals Inc.
AMPE
|
$1.88M |
| 3 |
InspireMD
NSPR
|
$875K |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$873K |
| 5 |
DMK
DMK Pharmaceuticals Corporation Common Stock
DMK
|
$795K |
Sector Composition
| 1 | Healthcare | 69.05% |
| 2 | Financials | 1.39% |